Clinical trial
Safety and Efficacy of the RENATUS® Transcatheter Aortic Valve System for the Treatment of Severe Aortic Stenosis
NCT07414342 is registered in ClinicalTrials.gov with Beijing Balance Medical Technology Co., Ltd as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Safety and Efficacy of the RENATUS® Transcatheter Aortic Valve System for the Treatment of Severe Aortic Stenosis
- Lead sponsor
- Beijing Balance Medical Technology Co., Ltd
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- February 28, 2026
- Completion date
- September 30, 2037
- Enrollment
- 800 (estimated)
- Sites
- 4
Conditions
As the registry lists them; a condition with its own page is linked.
severe aortic stenosis